UOC
INSP icon

UBS O'Connor’s Inspire Medical Systems INSP Stock Holding History

UBS O'Connor’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,522
Closed -$1.24M – 365
2025
Q2 		$1.24M Buy
9,522
+1,522
+19% +$221K 0.03% 188
2025
Q1 		$1.27M Buy
+8,000
New +$1.45M 0.03% 163
2024
Q4 		– Sell
-1,000
Closed -$211K – 502
2024
Q3 		$211K Sell
1,000
-3,585
-78% -$623K 0.01% 386
2024
Q2 		$614K Sell
4,585
-3,500
-43% -$662K 0.02% 352
2024
Q1 		$1.74M Sell
8,085
-400
-5% -$78.4K 0.05% 203
2023
Q4 		$1.73M Sell
8,485
-4,086
-33% -$662K 0.05% 198
2023
Q3 		$2.49M Buy
12,571
+4,300
+52% +$1.08M 0.04% 201
2023
Q2 		$2.69M Sell
8,271
-1,494
-15% -$427K 0.06% 215
2023
Q1 		$2.29M Buy
9,765
+465
+5% +$118K 0.05% 294
2022
Q4 		$2.34M Sell
9,300
-5,000
-35% -$1.07M 0.04% 427
2022
Q3 		$2.54M Buy
+14,300
New +$2.87M 0.03% 492

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS O'Connor's INSP Position: Q3 2025 in Review

UBS O'Connor sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 9,522 shares — an estimated $1.24M sold.

UBS O'Connor first reported a position in INSP in Q3 2022 and held it in 11 quarters. The position peaked at $2.69M in Q2 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • UBS O'Connor reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 9,522 Inspire Medical Systems shares in Q3 2025, an estimated $1.24M.
  • UBS O'Connor first reported a position in Inspire Medical Systems in Q3 2022 and held it in 11 quarters.
  • UBS O'Connor's Inspire Medical Systems position peaked at $2.69M in Q2 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.